Medtronic scored a double CE mark win for its PulseSelect pulsed field ablation (PFA) system, designed to treat atrial fibrillation, and the Nitron CryoConsole, designed to optimize workflow for ...

Medtronic has secured the first FDA green light for a pulsed field ablation system, bringing a new type of atrial fibrillation treatment to the U.S. By using short bursts of specifically tuned ...

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System The Sphere-360 catheter was ...

In a closely watched medical development, Medtronic edged out competitors in securing U.S. Food and Drug Administration approval for a new cardiac device designed to treat a specific type of irregular ...

A common treatment for atrial fibrillation sees a surgeon inserting a catheter into the heart, where the device emits either heat or cold energy to destroy and scar over the areas of the organ ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...

First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...

DUBLIN, Dec. 13, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the ...

Sphere-9 demonstrated 73.8% freedom from AFib vs. only 65.8% observed in the control arm. AFib is one of the most common and undertreated heart rhythm disorders, affecting more than 60 million people ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...